AstraZeneca PLC First Quarter Results 2011

Thursday, 28 April 2011

David Brennan, Chief Executive Officer said:

"Our first quarter revenue performance reflects the anticipated generic competition in the US and Western Europe, which we partially mitigated by our continued double digit growth in Emerging Markets. We remain focused on driving operating performance in order to invest in the development of innovative new products while providing attractive cash returns to shareholders."

First quarter results 2011

Announced on Thursday 28 April 2011



  • Corporate and financial